USPSTF Recommendation: Statin Use for Primary Prevention of CVD

Zusammenfassung

Final Recommendation Statement: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce Skip to main content Search the USPSTF Site Button Subscribe Toggle navigation Search the USPSTF Site Button Recommendations Search and Filter All Recommendations Standards for Guideline Development Grade Definitions USPSTF A&B Recommendations USPSTF Recommendations App - Prevention TaskForce Public Comments and Nominations

Kerninformationen

They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services. Download Final Recommendation Statement (PDF) Return to Recommendation Table of Contents Importance USPSTF Assessment of Magnitude of Net Benefi...

See the Table for more information on the USPSTF recommendation rationale and assessment. For more details on the methods the USPSTF uses to determine the net benefit, see the USPSTF Procedure Manual. 5 Return to Table of Contents Practice Considerations Patient Population Under Consideration These ...

The likelihood that a patient will benefit from statin use depends on their absolute risk of having a future CVD event, a risk estimation that, as noted above, is imprecise based on the currently available risk estimation tools. The higher a person’s 10-year risk of a CVD event, the greater th...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen